SAN RAMON, Calif., June 22, 2020—While COVID-19 continues to hinder travel and events, eye care professionals and industry partners are finding alternatives to the education, meetings and exhibits that typically take place at conferences. CooperVision has launched a virtual exhibit booth to provide would-be attendees a similar experience from the comfort and safety of their own homes.
The virtual booth, available at www.CooperVisionBooth.com, features a 3D rendering of CooperVision’s actual exhibit, as well as multimedia materials that showcase the latest news and product information from the company. Visitors will have the opportunity to:
- Learn how CooperVision is supporting eye care professionals and their practices during these unprecedented times;
- Explore CooperVision’s newest addition to the Biofinity® family—Biofinity® toric multifocal;
- Dive into information on the Brilliant Futures™ Myopia Management Program;
- Learn more about the recent expansion of prescription options for clariti® 1 day toric;
- Get to know CooperVision’s 2020 Best Practices honorees; and
- Discover the breadth of CooperVision’s commitment to sustainability.
“Conferences are always invaluable opportunities for us to connect with practitioners from around the country, share with them the most recent developments in product and partnership, and hear from them about what they want and need for their practices,” said Michele Andrews, OD, Senior Director of Professional and Academic Affairs, North America, CooperVision. “We’re disappointed not to have that face-to-face interaction right now, but we must adapt to continue our collaboration, even when we’re separated by distance. The virtual exhibit booth is part of that effort, offering our customers a convenient way to explore all of our latest news, all in one place.”
CooperVision plans to update the virtual exhibit booth with new information and materials as they are developed.
# # #
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of daily disposable, two-week and monthly contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism, presbyopia and childhood myopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
CooperCompanies (“Cooper”) is a global medical device company public traded on NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
McDougall Communications for CooperVision, Inc.
email@example.com or +1-585-434-2148